{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:54:06Z","timestamp":1790376846231,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41431-025-01991-x","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T16:52:15Z","timestamp":1766595135000},"page":"288-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A homozygous variant in the beta-1,3-N-acetylglucosaminyltransferase 4 gene causes progressive brain atrophy and muscular dystrophy"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6144-8544","authenticated-orcid":false,"given":"John","family":"Vissing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9227-2526","authenticated-orcid":false,"given":"Ana","family":"T\u00f6pf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9046-3540","authenticated-orcid":false,"given":"Volker","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9330-668X","authenticated-orcid":false,"given":"Thomas","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"1991_CR1","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1016\/j.febslet.2005.03.033","volume":"579","author":"F Saito","year":"2005","unstructured":"Saito F, Blank M, J\u00f6rn S, Manya H, Shimizu T, Campbell KP, et al. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy. FEBS Lett. 2005;579:2359\u201363.","journal-title":"FEBS Lett"},{"key":"1991_CR2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.61388","volume":"9","author":"AS Walimbe","year":"2020","unstructured":"Walimbe AS, Okuma H, Joseph S, Yang T, Yonekawa T, Hord JM, et al. POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan. Elife. 2020;9:e61388.","journal-title":"Elife"},{"key":"1991_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jb\/mvu066","volume":"157","author":"T Endo","year":"2015","unstructured":"Endo T. Glycobiology of \u03b1-dystroglycan and muscular dystrophy. J Biochem. 2015;157:1\u201312.","journal-title":"J Biochem"},{"key":"1991_CR4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/glycob\/cwv021","volume":"25","author":"T Yoshida-Moriguchi","year":"2015","unstructured":"Yoshida-Moriguchi T, Campbell KP. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Glycobiology. 2015;25:702\u201313.","journal-title":"Glycobiology"},{"key":"1991_CR5","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.bbagen.2017.06.024","volume":"1861","author":"H Manya","year":"2017","unstructured":"Manya H, Endo T. Glycosylation with ribitol-phosphate in mammals: new insights into the O-mannosyl glycan. Biochim Biophys Acta Gen Subj. 2017;1861:2462\u201372.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"1991_CR6","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1074\/jbc.M004800200","volume":"276","author":"N Shiraishi","year":"2001","unstructured":"Shiraishi N, Natsume A, Togayachi A, Endo T, Akashima T, Yamada Y, et al. Identification and characterization of three novel beta 1,3-N-acetylglucosaminyltransferases structurally related to the beta 1,3-galactosyltransferase family. J Biol Chem. 2001;276:3498\u2013507.","journal-title":"J Biol Chem"},{"key":"1991_CR7","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s41436-020-0840-3","volume":"22","author":"A T\u00f6pf","year":"2020","unstructured":"T\u00f6pf A, Johnson K, Bates A, Phillips L, Chao KR, England EM, et al. Sequential targeted exome sequencing of 1001 patients affected by unexplained limb\u2013girdle weakness. Genet Med. 2020;22:1478\u201388.","journal-title":"Genet Med"},{"key":"1991_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1991_CR9","first-page":"1137","volume":"74","author":"TO Krag","year":"2015","unstructured":"Krag TO, Vissing J. A new mouse model of Limb-Girdle muscular dystrophy type 2I homozygous for the common L276I mutation mimicking the mild phenotype in humans. J Neuropathol Exp Neurol. 2015;74:1137\u201346.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1991_CR10","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310\u201315.","journal-title":"Nat Genet"},{"key":"1991_CR11","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/gim.2017.210","volume":"20","author":"SV Tavtigian","year":"2018","unstructured":"Tavtigian SV, Greenblatt MS, Harrison SM, Nussbaum RL, Prabhu SA, Boucher KM, et al. Modeling the ACMG\/AMP variant classification guidelines as a Bayesian classification framework. Genet Med. 2018;20:1054\u201360.","journal-title":"Genet Med"},{"key":"1991_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.","journal-title":"Science"},{"key":"1991_CR13","doi-asserted-by":"publisher","first-page":"34843","DOI":"10.1074\/jbc.273.52.34843","volume":"273","author":"M Ujita","year":"1998","unstructured":"Ujita M, McAuliffe J, Schwientek T, Almeida R, Hindsgaul O, Clausen H, et al. Synthesis of poly-N-acetyllactosamine in core 2 branched O-glycans. The requirement of novel beta-1,4-galactosyltransferase IV and beta-1,3-n-acetylglucosaminyltransferase. J Biol Chem. 1998;273:34843\u201349.","journal-title":"J Biol Chem"},{"key":"1991_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1073\/pnas.96.2.406","volume":"96","author":"D Zhou","year":"1999","unstructured":"Zhou D, Dinter A, Guti\u00e9rrez Gallego R, Kamerling JP, Vliegenthart JF, Berger EG, et al. A beta-1,3-N-acetylglucosaminyltransferase with poly-N-acetyllactosamine synthase activity is structurally related to beta-1,3-galactosyltransferases. Proc Natl Acad Sci USA. 1999;96:406\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1991_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/glycob\/cwt116","volume":"24","author":"J Morise","year":"2014","unstructured":"Morise J, Kizuka Y, Yabuno K, Tonoyama Y, Hashii N, Kawasaki N, et al. Structural and biochemical characterization of O-mannose-linked human natural killer-1 glycan expressed on phosphacan in developing mouse brains. Glycobiology. 2014;24:314\u201324.","journal-title":"Glycobiology"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01991-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01991-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01991-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:46:09Z","timestamp":1769769969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01991-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1991"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01991-x","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The parents of the patient gave consent to all procedures, which followed institutional guidelines and were in accordance with the Helsinki declaration. The ethics committee of the Capital Region of Denmark exempted the study from normal approval as all procedures performed on the patient were part of the routine clinical workup. Genetic testing was approved by the Newcastle and North Tyneside research ethics committee (REC #09\/H0906\/28). Mice experiments were approved by the Danish Animal Inspectorate (permit #2019-15-0201-00286). MYO-SEQ was funded by Sanofi Genzyme, Ultragenyx, LGMD2I Research Fund, Samantha J. Brazzo Foundation, LGMD2D Foundation and Kurt+Peter Foundation, Muscular Dystrophy UK, and Coalition to Cure Calpain 3. Analysis was provided by the Broad Institute of MIT and Harvard Center for Mendelian Genomics (Broad CMG) and was funded by the National Human Genome Research Institute, the National Eye Institute, and the National Heart, Lung, and Blood Institute grant UM1 HG008900, and in part by National Human Genome Research Institute grant R01 HG009141.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}